Member Info for GLR1990

Has this been mentioned?
Shame I didnt see it before the webinar

https://www.yorkpress.co.uk/news/19054261.covid-antibody-test-developer-abingdon-health-completes-expansion-york/

Says we expanded the York Capacity

Interesting quote "when the request came in from abingdon" which must have been pretty recently, why are they frantically looking for more space if we are being left behind?

Depends who the two companies are

Would presume they are either manufacturers of the freezers, or distribution companies/governments

Doubt a small fry would invest in tracking, quite a significant overhead for what, just to tender for vaccine tracking contracts that they may not win?

So leaves manufacturers, but again they would be installed within the freeze, STAR devices likely being use for on the move/within transportation

So either A. Distribution company who has a large contract to distribute vaccines, or B. Governments

Hopefully B! But A would likely be lucrative

The MCAP is so small here that even old deals like the $1.1m NA order would send us up 30-50%

Extremely excited about Leap Gaming, the BasketBall Euroleague among other developments in Italy surely mean our holding is now worth more than the £7m back in September

I was thinking yesterday Portage was up over 100% and its listed, at some point you do need to take profits and if people want portage exposure then just buy it, ofc same could be said for Yooma but that has just listed and we have already doubled our worth, who knows as volume picks up we may take some out of that as well

Little Green investment again we could buy ourselves as PI's but personally would have not got that price in the placing so again very happy with that investment and I think it will do well in time, the DD from the team seems spot on last few Q's been very impressive, good find I would say and great price

All in all very exciting times

Slowly but surely getting back to £2

Think the FX business may struggle obviously with travel restrictions, but I think any loss in FX will be offset by a soaring Jewellery/Gold/Silver exchange and pawnbroking business

Still cash generative so more like the business growth has been put on hold whereas other companies have really struggle and had to raise funds / dilute

Few acquisitions would be nice

Just worked out our assets (if those not listed remain the same) are currently worth around £21/22m

This is not taking into account any price rise on Emmac Juven or Leap since September 2020

People sell at £18.5m MCAP

Long way to go but with IPO's the value will be realised

And someone sells at 87p again
Maybe next year rodders
Each to their own, surely pre-ipo stock as surely nobody selling at a loss here

11-Feb-21 17:04:03 87.986 460,000 Sell* 90.00 98.00 404.74k

£400K delayed sell, another £65K delayed so ~0.6% of the company

Might finally be close to clearing the seller(s)

Sorry 150m Per annum! Not per month!
So would be around 12m per month
We know current capacity is at least 1m per month, probably closer to 2m per month in Q2
ODX capacity as per last RNS is also loaned so I imagine their margins would be smaller, not to say thats a bad deal of course its a great deal and would welcome it here

ABDX doesn't have 15m a week its potentially 150m a month in 2022
In your first example, if #ODX makes £52m a year profit, then £150m MCAP is an absolute steal

Even if we match what ODX makes (IMHO we will exceed through having higher capacity, more experience and better facilities) the market cap should be way north of £200m

Asher when you mention food intolerance, we made £7m in revenue last year so ABDX also has more strings to its bow than just CV19 but let's all be real, without CV19 tests these companies are not sustaining their market caps so they both have to ensure revenue is brought in from the CV19 market and in substantial amounts, but nobody knows how long testing will be required in the UK and overseas, so significant company changing revenue looks likely

Pretty happy with that, 30% discount to the trading place
Cool $1m invested

Everyone likes Portage but I can see why they want to quickly rebrand as a CBD fund, might as well do a quick name change whilst they are at it (sounds silly but look at blockchain companies, some of them dont even mine BTC!)

Another shrewd purchase, the more the merrier, might as well get as many on board before this really takes off in the summer

Because there is a large seller behind the scenes, not helped by those ill informed articles
Anyone who sells £14K at 82p when the ask is currently 89p (now 87p) clearly doesn't care what price they get for their shares, they just want rid
Could be pre-IPO holders looking to cash in and move onto something else
As soon as we get a positive RNS this will be back over £1+

Very quiet on social media and on this BB considering we have just listed a cannabis stock on the CSE, where most are up 50%

Is our holding still 10.65%?

Also does anyone know the listing market cap of Yooma, I have read all the documents but cant seem to find the valuation?

Good post 441, clearly shows BBI and AB have been involved with the government and moonshot for some time
Whatever the chosen LFT may be, I am sure both BBI and ABDX will be involved in the manufacturing at some point
ODX now £200m MCAP vs ABDX £80m, we could double from here easily

PL almost bought Avacta today but had to pick up more of these
Wanted 120 so I can at least say I paid the same as Cuniff , I think it is largely derisked now even on the Se/Sp side with Mologic Involved

ABDX will increase capacity to ~12m per month which is 50% higher than the anticipated capacity from Omega, of course with revenues from the Mologic test we can expect Omega to increase further

ABDX with 12m capacity PCM are not just going to sit there, it will be fulfilled in one way or another - at the moment there is very little UK capacity, hence the large orders coming from China, Mologic / Omega / BBI and a few others make up the majority of it, along with ABDX - so in no scenario do I see every other competitor manufacturing tests and arguably ABDX the largest in Europe with the most experience sitting there with nothing to do

Also people saying 'bit late' - no it isn't, TT takes about three months, they have three antigen tests already in process if not completed and they still have the antibody test, although the jury is currently out on that

Thanks Tony forgot about that, about to sign up now

Can't believe people are selling this at 85p
Any Idea who the three Antigen Tests in TT are?

We know one is Avacta, who are the other two?

Fair enough that would be great but I dont think they would look at debt/fundraising

Would likely be a share/cash offer from existing resources

Would be great for the SP

Am I on the right board or are we getting confused with ARB who obviously could raise debt for more machines and therefore more revenue (Like MARA and RIOT, even though they did just raise £20m at 80p for more machines)

Genuine Q what type of debt raise are you referring to and what would it be for?

I doubt an influx of users costs them much, maybe need another server(s) and a few more staff members, £200K cost per annum if that?

Huh? What are you talking about, debt?

For what?

They probably have access to at least £7m inc. the bitcoin holding